Učitavanje...

Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease

All-oral, direct-acting antivirals (DAAs) have significantly improved the efficacy and safety of chronic hepatitis C (CHC) treatment but their effectiveness and safety among patients with chronic kidney disease (CKD) remains poorly understood. Our aim was to assess the efficacy and safety of DAAs fo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Therap Adv Gastroenterol
Glavni autori: Kohli, Anita, Alshati, Ali, Georgie, Fawaz, Manch, Richard, Gish, Robert G.
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2016
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5076774/
https://ncbi.nlm.nih.gov/pubmed/27803742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X16665254
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!